Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCRX compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name
BCRX
Biocryst Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCRX
Biocryst Pharmaceuticals Inc
vs
MNPR
Monopar Therapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
BCRX
with
MNPR
Uncorrelated: r 0.04 · 501D.
No shared co-movers.
BCRX, solid
MNPR, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
BCRX
Biocryst Pharmaceuticals Inc
Change
8.69
▲
+1.44%
Mkt cap
$2.2B
Revenue
$218M
Q2 FY26
Revenue
$875M
FY25
MNPR
Monopar Therapeutics
Change
71.12
▲
+1.76%
Regular session
Nov 4 '26
Mkt cap
$469.1M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 4 '26
BCRX
Biocryst Pharmaceuticals Inc
vs
MNPR
Monopar Therapeutics
8.69
▲
+1.44%
Price
71.12
▲
+1.76%
$2.2B
Mkt cap
$469.1M
Q2 FY26
$218M
Revenue
—
FY25
$875M
Revenue
—
Change
Change
BCRX
8.69
▲
+1.44%
vs
MNPR
71.12
▲
+1.76%
Regular session
Nov 4 '26